Dr. Prasanth Ravipati

Claim this profile

University of Nebraska

Studies Membranous Glomerulonephritis
Studies Kidney Disease
1 reported clinical trial
2 drugs studied

Affiliated Hospitals

Image of trial facility.
University Of Nebraska

More about Prasanth Ravipati

Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Prasanth Ravipati has experience with
  • Belimumab
  • Rituximab
Breakdown of trials Prasanth Ravipati has run
Membranous Glomerulonephritis

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Prasanth Ravipati specialize in?
Prasanth Ravipati focuses on Membranous Glomerulonephritis and Kidney Disease. In particular, much of their work with Membranous Glomerulonephritis has involved anti-PLA2R positive patients, or patients who are undergoing treatment.
Is Prasanth Ravipati currently recruiting for clinical trials?
No, Prasanth Ravipati is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Prasanth Ravipati has studied deeply?
Yes, Prasanth Ravipati has studied treatments such as Belimumab, Rituximab.
What is the best way to schedule an appointment with Prasanth Ravipati?
Apply for one of the trials that Prasanth Ravipati is conducting.
What is the office address of Prasanth Ravipati?
The office of Prasanth Ravipati is located at: University of Nebraska, Omaha, Nebraska 68198 United States. This is the address for their practice at the University of Nebraska.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.